OrthoLogic to Host Conference Call Discussing First Quarter 2006 Results
27 Avril 2006 - 4:00PM
PR Newswire (US)
TEMPE, Ariz., April 27 /PRNewswire-FirstCall/ -- OrthoLogic Corp.
(NASDAQ:OLGC) announced today that it will release financial and
operating results for 1Q2006 on Thursday, May 4, 2006. Management
will host a conference call and Webcast the same day at 9:00AM EDT
(6:00AM MT). The call may be accessed at 866-825-1692 (domestic) or
617- 213-8059 (international), with access code 66209515, or by
logging onto the Investors section of the Company's Web site,
http://www.orthologic.com/ . A replay will be available beginning
May 4, 2006, at 11:00 AM EDT until May, 18, 2006, and may be
accessed at 888-286-8010 (domestic) or 617-801-6888
(international), with access code 19681555. About OrthoLogic
OrthoLogic is a biotechnology company committed to developing a
pipeline of novel peptides and other molecules aimed at helping
patients with under- served conditions. The Company is focused on
the development and commercialization of two product platforms:
Chrysalin(R) (TP508) and AZX100. Chrysalin, the Company's novel
synthetic 23-amino acid peptide, is being studied in two lead
indications, both of which represent areas of significant unmet
medical need -- fracture repair and diabetic foot ulcer healing.
Based on the Company's pioneering scientific research of the
natural healing cascade, OrthoLogic has become a leading company
focused on tissue and bone repair. The Company owns exclusive
worldwide rights to Chrysalin. AZX100 is a novel synthetic 24-amino
acid peptide, the first of a new class of compounds in the field of
smooth muscle relaxation called Intracellular Actin Relaxing
Molecules, or ICARMs(TM). AZX100 is currently being evaluated for
medically and commercially significant applications, such as the
treatment of vasospasm associated with subarachnoid hemorrhage, the
prevention of keloid scarring and the treatment of asthma.
OrthoLogic has an exclusive worldwide license to AZX100.
DATASOURCE: OrthoLogic CONTACT: Investors, Melanie Friedman for
OrthoLogic, +1-212-362-1200 or Web site: http://www.orthologic.com/
Copyright
Orthologic (MM) (NASDAQ:OLGC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Orthologic (MM) (NASDAQ:OLGC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Orthologic (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Orthologic (MM)